Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Hair transplantation is safe and effective for permanent hair loss due to scarring, with high patient satisfaction.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Adding nano fat to hair transplants improves results for scar-related hair loss.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Early diagnosis and treatment can reduce cicatricial alopecia in middle-aged individuals, especially females.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Hair transplants can work for permanent hair loss if the condition is stable and done carefully.